- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.22 Å
- Oligo State
- monomer
- Ligands
- 1 x MG9: 2-{4-[(2S)-4-[(6-aminopyridin-3-yl)sulfonyl]-2-(prop-1-yn-1-yl)piperazin-1-yl]phenyl}-1,1,1,3,3,3-hexafluoropropan-2-ol(Non-covalent)
- 1 x S6P: D-SORBITOL-6-PHOSPHATE(Non-covalent)
S6P.2: 15 residues within 4Å:- Chain A: G.118, G.119, T.120, S.121, E.161, E.164, S.190, V.191, G.192, A.195, S.268, S.269, R.270, H.362, K.525
20 PLIP interactions:20 interactions with chain A- Hydrogen bonds: A:T.120, A:T.120, A:T.120, A:S.121, A:S.121, A:V.191, A:G.192, A:A.195, A:G.267, A:S.269, A:S.269, A:R.270, A:H.362, A:T.363, A:K.525
- Water bridges: A:S.121, A:E.161, A:E.164, A:E.164
- Salt bridges: A:K.525
- 13 x IOD: IODIDE ION(Non-functional Binders)
IOD.3: 5 residues within 4Å:- Chain A: F.477, E.478, Y.479, F.483, I.484
Ligand excluded by PLIPIOD.4: 1 residues within 4Å:- Chain A: V.612
Ligand excluded by PLIPIOD.5: 2 residues within 4Å:- Chain A: R.84, G.261
Ligand excluded by PLIPIOD.6: 1 residues within 4Å:- Chain A: T.309
Ligand excluded by PLIPIOD.7: 3 residues within 4Å:- Chain A: D.56, A.57, L.507
Ligand excluded by PLIPIOD.8: 2 residues within 4Å:- Chain A: R.160, G.162
Ligand excluded by PLIPIOD.9: 2 residues within 4Å:- Chain A: Q.540, S.541
Ligand excluded by PLIPIOD.10: 3 residues within 4Å:- Chain A: G.14, K.16, A.565
Ligand excluded by PLIPIOD.11: 4 residues within 4Å:- Chain A: E.36, K.44, S.45
- Ligands: MG9.1
Ligand excluded by PLIPIOD.12: 2 residues within 4Å:- Chain A: F.18, K.542
Ligand excluded by PLIPIOD.13: 2 residues within 4Å:- Chain A: L.456, S.469
Ligand excluded by PLIPIOD.14: 3 residues within 4Å:- Chain A: C.204, N.207, W.233
Ligand excluded by PLIPIOD.15: 3 residues within 4Å:- Chain A: T.24, G.539, S.541
Ligand excluded by PLIP- 1 x GOL: GLYCEROL(Non-functional Binders)
- 3 x SO4: SULFATE ION(Non-functional Binders)
SO4.17: 4 residues within 4Å:- Chain A: D.53, K.54, A.55, D.56
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:K.54
SO4.18: 3 residues within 4Å:- Chain A: K.29, L.32, S.33
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:L.32
- Salt bridges: A:K.29
SO4.19: 3 residues within 4Å:- Chain A: Q.347, T.348, L.375
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- St Jean, D.J. et al., Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 2. Leveraging structure-based drug design to identify analogues with improved pharmacokinetic profiles. J.Med.Chem. (2014)
- Release Date
- 2014-05-07
- Peptides
- Glucokinase regulatory protein: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.22 Å
- Oligo State
- monomer
- Ligands
- 1 x MG9: 2-{4-[(2S)-4-[(6-aminopyridin-3-yl)sulfonyl]-2-(prop-1-yn-1-yl)piperazin-1-yl]phenyl}-1,1,1,3,3,3-hexafluoropropan-2-ol(Non-covalent)
- 1 x S6P: D-SORBITOL-6-PHOSPHATE(Non-covalent)
- 13 x IOD: IODIDE ION(Non-functional Binders)
- 1 x GOL: GLYCEROL(Non-functional Binders)
- 3 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- St Jean, D.J. et al., Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 2. Leveraging structure-based drug design to identify analogues with improved pharmacokinetic profiles. J.Med.Chem. (2014)
- Release Date
- 2014-05-07
- Peptides
- Glucokinase regulatory protein: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
B